Literature DB >> 25054896

Brain cancer translational research from an academic perspective.

Gregory Riggins1, Simi Thankaraj.   

Abstract

Dr Gregory Riggins speaks to Simi Thankaraj, Assistant Commisioning Editor: Gregory J Riggins is the recipient of the Irving J Sherman MD Research Professorship in Neurosurgery and the Director of the Division of Neurosurgery Research. He received his MD and PhD degrees from Emory University (GA, USA) where he graduated from the Medical Scientist Training Program. After graduation, he then trained as a postdoctoral fellow with Bert Vogelstein and Ken Kinzler at the Johns Hopkins University (MD, USA) in the Department of Oncology. Now a Professor of Neurosurgery and Oncology, and Genetic Medicine at Johns Hopkins, the main goal of his research is to develop and evaluate new brain tumor therapies. A major component of this research is identifying new small molecules.

Entities:  

Mesh:

Year:  2014        PMID: 25054896      PMCID: PMC6128198          DOI: 10.2217/cns.13.57

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  3 in total

1.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  Evaluation of Clostridium novyi-NT spores in dogs with naturally occurring tumors.

Authors:  Erika L Krick; Karin U Sorenmo; Shelley C Rankin; Ian Cheong; Barry Kobrin; Katherine Thornton; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou; Luis A Diaz
Journal:  Am J Vet Res       Date:  2012-01       Impact factor: 1.156

3.  5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft.

Authors:  Alexandra Borodovsky; Vafi Salmasi; Sevin Turcan; Armida W M Fabius; Gilson S Baia; Charles G Eberhart; Jon D Weingart; Gary L Gallia; Stephen B Baylin; Timothy A Chan; Gregory J Riggins
Journal:  Oncotarget       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.